|
 |
SALT LAKE CITY, March 25, 2010—BSD Medical Corporation (“BSD”) (NASDAQ:BSDM) today reported that hyperthermia research was recently highlighted in a television segment that aired on WRAL-TV5, Raleigh’s CBS affiliated television station.
The story can be viewed at: www.wral.com/lifestyles/healthteam/video/7141430. The segment previews the innovative and exciting research being conducted on hyperthermia at Duke University Medical Center. The research reported in the segment utilizes BSD’s hyperthermia systems.
Duke University Medical Center is a world-class academic and health care system that strives to transform medicine and health locally and globally through innovative scientific research. Duke University Medical Center is a world-wide leader in research into hyperthermia.
About BSD Medical Corporation
BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radio frequency (RF) and microwave energy. BSD’s product lines include both hyperthermia and ablation treatment systems. BSD’s hyperthermia cancer treatment systems, which have been in use for several years in the United States, Europe and Asia, are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other therapies such as radiation therapy. BSD’s microwave ablation system, which the Company will introduce to the market this year, has been developed as a stand-alone therapy to employ precision-guided microwave energy to ablate (destroy) soft tissue. The Company has extensive intellectual property, multiple products in the market and well established distribution in the United States, Europe and Asia. Certain of the Company’s products have received regulatory approvals in the United States, Europe and China. For further information visit BSD Medical's website at www.BSDMedical.com.
###
Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date.
|
|
|
